• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恐惧问卷。关于效度、信度和布局的一些数据。

The fear questionnaire. Some data on validity, reliability and layout.

作者信息

Van Zuuren F J

机构信息

Department of Clinical Psychology, University of Amsterdam, The Netherlands.

出版信息

Br J Psychiatry. 1988 Nov;153:659-62. doi: 10.1192/bjp.153.5.659.

DOI:10.1192/bjp.153.5.659
PMID:3255455
Abstract

In order to assess some psychometric properties of Marks & Mathews' (1979) short Fear Questionnaire, a Dutch translation of this form was administered to 143 phobic outpatients: 100 women and 43 men. There was a special interest in assessing validity by comparing the scores of agoraphobics, social phobics and simple phobics. The findings were that all scales have sufficient internal consistency, although the Total Phobia scale does not seem to add meaningful information to its subscales. Most scales are significantly related to neuroticism, and the Social Phobia subscale is strongly related to social anxiety. The Agoraphobia and Social Phobia subscales discriminate between categories of phobics in the expected way. For the Blood/Injury subscale the relevant comparisons could not be made. The data presented in this study can be used to develop FQ norms for phobic patients.

摘要

为了评估马克斯和马修斯(1979年)编制的简短恐惧问卷的一些心理测量特性,我们将该问卷的荷兰语译本施测于143名恐惧障碍门诊患者,其中100名女性,43名男性。通过比较广场恐惧症患者、社交恐惧症患者和单纯恐惧症患者的得分来评估效度,这一点受到特别关注。研究结果表明所有分量表都具有足够的内部一致性,尽管恐惧总分量表似乎并没有为其子量表增添有意义的信息。大多数分量表与神经质显著相关,社交恐惧症分量表与社交焦虑密切相关。广场恐惧症和社交恐惧症分量表以预期的方式区分了不同类型的恐惧症患者。对于血液/损伤分量表,无法进行相关比较。本研究中呈现的数据可用于制定恐惧障碍患者的恐惧问卷常模。

相似文献

1
The fear questionnaire. Some data on validity, reliability and layout.恐惧问卷。关于效度、信度和布局的一些数据。
Br J Psychiatry. 1988 Nov;153:659-62. doi: 10.1192/bjp.153.5.659.
2
Value of the Fear Questionnaire in differentiating agoraphobia and social phobia.恐惧问卷在区分广场恐惧症和社交恐惧症中的价值。
Br J Psychiatry. 1991 Dec;159:842-5. doi: 10.1192/bjp.159.6.842.
3
[Validation and factor analysis of a phobia scale. The French version of the Marks-Mathews fear questionnaire].[恐惧症量表的效度验证与因素分析。马克斯 - 马修斯恐惧问卷的法语版本]
Encephale. 1987 Jan-Feb;13(1):23-9.
4
Reliability and validity of the work and social adjustment scale in phobic disorders.恐惧症中工作与社会适应量表的信度和效度
Compr Psychiatry. 2005 May-Jun;46(3):223-8. doi: 10.1016/j.comppsych.2004.08.007.
5
Utility of fear survey schedule with Australian samples of anxiety disorder patients.恐惧调查量表在澳大利亚焦虑症患者样本中的效用。
J Behav Ther Exp Psychiatry. 1987 Dec;18(4):329-36. doi: 10.1016/0005-7916(87)90047-4.
6
A psychometric reanalysis of the Albany Panic and Phobia Questionnaire.《奥尔巴尼恐慌与恐惧症问卷》的心理测量再分析
Behav Res Ther. 2005 Mar;43(3):337-55. doi: 10.1016/j.brat.2004.03.004.
7
Confirmatory factor analysis of the Fear Questionnaire with social phobia patients.对社交恐惧症患者进行恐惧问卷的验证性因素分析。
Br J Psychiatry. 1996 Apr;168(4):497-9. doi: 10.1192/bjp.168.4.497.
8
Primary and secondary social phobia: psychopathologic and familial differentiations.原发性和继发性社交恐惧症:精神病理学及家族差异
Compr Psychiatry. 1990 May-Jun;31(3):245-52. doi: 10.1016/0010-440x(90)90008-g.
9
Change in danger cognitions in agoraphobia and social phobia during treatment.
Behav Res Ther. 1996 May-Jun;34(5-6):413-21. doi: 10.1016/0005-7967(96)00009-5.
10
[Evaluation of Post-traumatic Stress Disorder: validation of a measure, the PCLS].[创伤后应激障碍的评估:一种测量工具——创伤后应激障碍检查表(PCLS)的效度验证]
Encephale. 2003 May-Jun;29(3 Pt 1):232-8.

引用本文的文献

1
Transdiagnostic factors predicting the 2-year disability outcome in patients with anxiety and depressive disorders.预测焦虑和抑郁障碍患者 2 年残疾结局的跨诊断因素。
BMC Psychiatry. 2023 Jun 16;23(1):443. doi: 10.1186/s12888-023-04919-1.
2
Eye movement desensitization and reprocessing (EMDR) therapy or supportive counseling prior to exposure therapy in patients with panic disorder: study protocol for a multicenter randomized controlled trial (IMPROVE).眼动脱敏再处理(EMDR)疗法或支持性咨询在惊恐障碍患者暴露疗法之前的应用:一项多中心随机对照试验(IMPROVE)的研究方案。
BMC Psychiatry. 2023 Mar 14;23(1):157. doi: 10.1186/s12888-022-04320-4.
3
Temporal relationships between happiness and psychiatric disorders and their symptom severity in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA).
在一项大型队列研究中:荷兰抑郁和焦虑研究(NESDA),幸福感与精神障碍及其症状严重程度之间的时间关系。
BMC Psychiatry. 2021 Jul 10;21(1):344. doi: 10.1186/s12888-021-03346-4.
4
Anxiety disorders.焦虑症。
Lancet. 2021 Mar 6;397(10277):914-927. doi: 10.1016/S0140-6736(21)00359-7. Epub 2021 Feb 11.
5
Internet-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Open Community Versus Clinical Service Recruitment: Meta-Analysis.开放式社区招募与临床服务招募中基于互联网的焦虑症认知行为疗法:荟萃分析
J Med Internet Res. 2019 Apr 17;21(4):e11706. doi: 10.2196/11706.
6
Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial.大麻二酚增强治疗难治性恐惧症患者的暴露疗法:一项随机对照试验的研究方案。
BMC Psychiatry. 2019 Feb 13;19(1):69. doi: 10.1186/s12888-019-2022-x.
7
Adherence to a web-based pre-treatment for phobias in outpatient clinics.门诊诊所中对恐惧症基于网络的预处理的依从性。
Internet Interv. 2017 Jun 1;9:38-45. doi: 10.1016/j.invent.2017.05.004. eCollection 2017 Sep.
8
Not urbanization level but socioeconomic, physical and social neighbourhood characteristics are associated with presence and severity of depressive and anxiety disorders.不是城市化水平,而是社会经济、物质和社会邻里特征与抑郁和焦虑障碍的存在和严重程度有关。
Psychol Med. 2019 Jan;49(1):149-161. doi: 10.1017/S0033291718000612. Epub 2018 Mar 15.
9
Experiential Avoidance and Bordering Psychological Constructs as Predictors of the Onset, Relapse and Maintenance of Anxiety Disorders: One or Many?经验性回避及相关心理结构作为焦虑症发作、复发和维持的预测因素:是单一因素还是多种因素?
Cognit Ther Res. 2017;41(6):867-880. doi: 10.1007/s10608-017-9856-7. Epub 2017 May 10.
10
Long-term disability in anxiety disorders.焦虑症的长期残疾状况。
BMC Psychiatry. 2016 Jul 19;16:248. doi: 10.1186/s12888-016-0946-y.